LJHT
TVRD

Laurie J. Hall Trustee’s Tvardi Therapeutics TVRD Stock Holding History

Laurie J. Hall Trustee’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$3K – 327
2022
Q4 		$3K Sell
7
-4
-36% -$1.52K ﹤0.01% 280
2022
Q3 		$4K Sell
11
-5
-31% -$1.81K ﹤0.01% 290
2022
Q2 		$5K Hold
16
– – ﹤0.01% 289
2022
Q1 		$7K Buy
16
+9
+129% +$3.69K ﹤0.01% 289
2021
Q4 		$3K Hold
7
– – ﹤0.01% 312
2021
Q3 		$4K Sell
7
-4
-36% -$2.01K ﹤0.01% 308
2021
Q2 		$6K Hold
11
– – ﹤0.01% 299
2021
Q1 		$8K Hold
11
– – ﹤0.01% 297
2020
Q4 		$6K Hold
11
– – ﹤0.01% 299
2020
Q3 		$5K Buy
+11
New +$6.39K ﹤0.01% 294
2019
Q4 		$4K Buy
8
+4
+100% +$2.81K ﹤0.01% 308
2019
Q3 		$3K Buy
+4
New +$3.33K ﹤0.01% 309

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurie J. Hall Trustee's TVRD Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 7 shares — an estimated $3K sold.

Laurie J. Hall Trustee first reported a position in TVRD in Q3 2019 and held it in 12 quarters. The position peaked at $8K in Q1 2021. 163 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 7 Tvardi Therapeutics shares in Q1 2023, an estimated $3K.
  • Laurie J. Hall Trustee first reported a position in Tvardi Therapeutics in Q3 2019 and held it in 12 quarters.
  • Laurie J. Hall Trustee's Tvardi Therapeutics position peaked at $8K in Q1 2021.
  • 163 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.